Wilson Matthew G, Webb Taylor D, Odéen Henrik, Kubanek Jan
bioRxiv. 2024 Mar 28:2023.10.09.561539. doi: 10.1101/2023.10.09.561539.
Many areas of science and medicine would benefit from selective release of drugs in specific regions of interest. Nanoparticle drug carriers activated by focused ultrasound-remotely applied, depth-penetrating energy-may provide such selective interventions. Here, we developed stable, ultrasound-responsive nanoparticles that can be used to release drugs effectively and safely in non-human primates. The nanoparticles were used to release propofol in deep brain visual regions. The release reversibly modulated the subjects' visual choice behavior and was specific to the targeted region and to the released drug. Gadolinium-enhanced MRI imaging suggested an intact blood-brain barrier. Blood draws showed normal clinical chemistry and hematology. In summary, this study provides a safe and effective approach to release drugs on demand in selected deep brain regions at levels sufficient to modulate behavior.
科学和医学的许多领域将受益于在特定感兴趣区域选择性释放药物。由聚焦超声(远程应用、具有深度穿透能力的能量)激活的纳米颗粒药物载体可能提供这种选择性干预。在此,我们开发了稳定的、对超声有响应的纳米颗粒,可用于在非人类灵长类动物中有效且安全地释放药物。这些纳米颗粒被用于在深部脑视觉区域释放丙泊酚。这种释放可逆地调节了受试者的视觉选择行为,并且对靶向区域和释放的药物具有特异性。钆增强磁共振成像表明血脑屏障完整。血液检测显示临床化学和血液学指标正常。总之,本研究提供了一种安全有效的方法,可在选定的深部脑区域按需释放药物,释放水平足以调节行为。